Syschem (India) Ltd

SYSCHEM

Watchlist

AI Mode

‌

Market Cap

₹ 210 Cr

P/E

46.49

‌

‌
‌

‌

‌
‌

Investment Checklist

How to read checklist?

Performance

STEADY PERFORMER

Valuation

REASONABLE

Growth

STABLE

Profitability

MODERATE MARGIN

Technicals

Bearish

Risk

MODERATE RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Syschem (India) Limited manufactures bulk drugs, intermediates, and provides contract manufacturing services. The company consistently enhances revenue and profitability through operational efficiency and backward integration. It is committed to environmentally sustainable practices and quality assurance, underpinning its trusted reputation in the pharmaceutical sector. A new manufacturing facility under construction will adhere to WHO-GMP standards, boosting its production capacity significantly.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

Market Cap

210 Cr

Volatility

Moderate Risk

P/E Ratio

46.5

Industry P/E

30.8

PEG Ratio

—

P/B Ratio

2.2

52W High

62.00

52W Low

35.33

Sales CAGR

65.42%

80.54%

34.42%

10Y

67.52%

Profit CAGR

-83.33%

—

10Y

—

ROE

TTM

4.78%

4.54%

0.25%

10Y

-1.74%

ROCE

TTM

5.68%

5.54%

0.89%

10Y

-0.63%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
LYKALABS	77.30	276 Cr	135.61	2.73	0.00	2.03	4.68	1.50
AMBASARABH	29.09	223 Cr	14.26	1.51	0.00	10.60	10.22	3.70
SYSCHEM	48.55	210 Cr	46.49	2.22	0.00	4.78	5.68	2.49
NATCAPSUQ	186.00	192 Cr	—	0.85	0.00	-4.87	-1.11	-2.84
ALPA	80.08	170 Cr	9.11	0.93	0.00	10.18	12.57	7.85
BALAXI	29.04	160 Cr	11.04	0.67	0.00	6.09	7.48	4.50
SOTAC	123.40	136 Cr	17.76	2.56	0.00	15.37	16.39	8.19

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	43	37	44	75	88	48	78	119	109	104
Expenses	41	35	43	73	87	47	77	117	107	100
Operating Profit	2.46	1.85	1.07	1.62	0.81	0.07	1.20	1.90	2.47	3.30
OPM %	5.71	4.99	2.45	2.17	0.93	0.15	1.54	1.60	2.26	3.19
Other Income	0.00	0.00	0.01	0.15	0.01	0.00	0.02	0.02	0.01	0.01
Interest	0.10	0.03	0.11	0.01	0.00	0.03	0.04	0.00	0.04	0.01
Depreciation	0.68	0.70	0.74	0.67	0.68	0.68	0.68	0.91	0.76	0.76
Profit Before Tax	1.68	1.12	0.23	1.09	0.14	-0.64	0.50	1.01	1.67	2.55
Tax %	0.00	0.00	0.00	123.85	0.00	0.00	0.00	54.46	0.00	25.49
Net Profit	1.68	1.12	0.23	-0.26	0.14	-0.64	0.50	0.46	1.67	1.90
EPS in Rs	0.39	0.26	0.05	-0.06	0.03	-0.15	0.12	0.11	0.38	0.34

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	14	77	110	88	74	66	130	233	386	353
Expenses	13	63	90	77	80	65	122	226	382	348
Operating Profit	0.95	13	20	11	-5.16	0.57	8.65	6.98	3.98	5.64
OPM %	7.03	17.10	18.31	12.46	-6.93	0.86	6.63	2.99	1.03	1.60
Other Income	0.00	-0.18	0.08	0.09	0.26	0.13	0.25	0.17	0.04	NaN
Interest	0.03	0.15	0.01	0.02	0.06	0.28	0.04	0.25	0.07	0.11
Depreciation	2.05	2.08	2.15	2.15	2.35	2.58	2.70	2.79	2.95	3.03
Profit Before Tax	-2.14	0.60	1.50	-2.20	-7.31	-2.17	6.15	4.11	1.01	2.54
Tax %	30.50	43.92	49.94	15.78	23.91	21.44	26.62	32.86	54.52	21.65
Net Profit	-1.49	0.34	0.75	-1.85	-5.57	-1.71	4.51	2.76	0.46	1.99
EPS in Rs	-0.38	0.14	0.16	-0.43	-1.28	-0.40	1.08	0.64	0.11	0.95
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	16	16	16	19	19	22	23	32	40	44
Reserves	-8.15	-8.64	-7.14	-6.77	-8.78	-14	-16	-9.59	17	48
Borrowings	27	20	19	15	16	15	1.75	1.61	0.45	0.00
Other Liabilities	12	17	29	35	36	55	51	69	107	126
Total Liabilities	47	44	58	62	62	77	60	93	164	217
Fixed Assets	32	29	29	27	28	30	32	31	31	53
CWIP	0.61	0.90	0.31	0.01	0.66	0.98	0.00	0.15	4.11	0.29
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	15	14	28	35	34	46	28	62	129	164
Total Assets	47	44	58	62	62	77	60	93	164	217

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	0.47	6.38	0.01	-1.71	3.46	3.72	1.07	-8.49	-26	-10
Cash from Investing Activity	0.09	0.35	0.29	1.83	-3.62	-3.77	-0.78	-1.65	-6.46	-22
Cash from Financing Activity	-0.54	-6.80	-0.15	-0.01	-0.02	-0.06	-0.28	11	32	34
Net Cash Flow	0.02	-0.07	0.14	0.11	-0.18	-0.11	0.00	0.54	-0.48	2.04

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Jun 2023	Sep 2023	Nov 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Apr 2025	Jun 2025	Sep 2025
Promoters	53.82%	53.79%	56.29%	53.89%	53.89%	53.89%	53.17%	53.17%	57.02%	57.02%	56.71%	56.71%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.00%	0.00%	0.00%	0.14%	0.25%	0.25%	0.20%	0.20%	0.18%	0.18%	0.18%	0.18%
Public	46.18%	46.21%	43.71%	45.97%	45.86%	45.86%	46.63%	46.63%	42.80%	42.80%	43.11%	43.11%
Total Shareholders	10,329	12,186	12,743	12,571	13,942	13,310	13,305	13,445	13,223	13,223	12,906	13,273

Market Transactions

Date	Party	Category	Type	Avg Price (₹)	Total Value (₹)	Quantity	Percent Traded
May 31, 2025	Ruchika jain	Insider - Promoter Group	Disposal	46.14	0.28 Cr	60,000	0.13
May 24, 2025	Ranjan jain	Insider - Promoter & Director	Disposal	42.06	0.32 Cr	75,336	0.17
Mar 27, 2025	Ruchika jain	Insider - Promoter Group	Disposal	49.25	1.97 Cr	4,00,000	0.91
Mar 27, 2025	Suninder veer singh	Insider - Promoter & Director	Acquisition	49.25	1.97 Cr	4,00,000	0.91
Mar 27, 2025	Ranjan jain	Insider - Promoter & Director	Disposal	39.87	0.14 Cr	34,987	0.08
Mar 06, 2025	Mahesh j khokhani	Insider - Promoter	Acquisition	49.00	3.00 Cr	6,12,500	1.53
Mar 06, 2025	Virendra popatlal shah	Insider - Promoter	Acquisition	49.00	3.12 Cr	6,37,500	1.59
Mar 06, 2025	Bhavesh virendra shah	Insider - Promoter	Acquisition	49.00	3.61 Cr	7,37,500	1.84
Mar 06, 2025	Bimal virendra shah	Insider - Promoter	Acquisition	49.00	3.00 Cr	6,12,500	1.53
Mar 06, 2025	Mehul j khokhani	Insider - Promoter	Acquisition	49.00	2.63 Cr	5,37,500	1.34

Projection

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q1 FY26

Investor Presentation

Q4 FY25

Investor Presentation

Q4 FY23

Investor Presentation

Q2 FY23

Investor Presentation

Q1 FY23

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	43	37	44	75	88	48	78	119	109	104
Expenses	41	35	43	73	87	47	77	117	107	100
Operating Profit	2.46	1.85	1.07	1.62	0.81	0.07	1.20	1.90	2.47	3.30
OPM %	5.71	4.99	2.45	2.17	0.93	0.15	1.54	1.60	2.26	3.19
Other Income	0.00	0.00	0.01	0.15	0.01	0.00	0.02	0.02	0.01	0.01
Interest	0.10	0.03	0.11	0.01	0.00	0.03	0.04	0.00	0.04	0.01
Depreciation	0.68	0.70	0.74	0.67	0.68	0.68	0.68	0.91	0.76	0.76
Profit Before Tax	1.68	1.12	0.23	1.09	0.14	-0.64	0.50	1.01	1.67	2.55
Tax %	0.00	0.00	0.00	123.85	0.00	0.00	0.00	54.46	0.00	25.49
Net Profit	1.68	1.12	0.23	-0.26	0.14	-0.64	0.50	0.46	1.67	1.90
EPS in Rs	0.39	0.26	0.05	-0.06	0.03	-0.15	0.12	0.11	0.38	0.34

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	14	77	110	88	74	66	130	233	386	353
Expenses	13	63	90	77	80	65	122	226	382	348
Operating Profit	0.95	13	20	11	-5.16	0.57	8.65	6.98	3.98	5.64
OPM %	7.03	17.10	18.31	12.46	-6.93	0.86	6.63	2.99	1.03	1.60
Other Income	0.00	-0.18	0.08	0.09	0.26	0.13	0.25	0.17	0.04	NaN
Interest	0.03	0.15	0.01	0.02	0.06	0.28	0.04	0.25	0.07	0.11
Depreciation	2.05	2.08	2.15	2.15	2.35	2.58	2.70	2.79	2.95	3.03
Profit Before Tax	-2.14	0.60	1.50	-2.20	-7.31	-2.17	6.15	4.11	1.01	2.54
Tax %	30.50	43.92	49.94	15.78	23.91	21.44	26.62	32.86	54.52	21.65
Net Profit	-1.49	0.34	0.75	-1.85	-5.57	-1.71	4.51	2.76	0.46	1.99
EPS in Rs	-0.38	0.14	0.16	-0.43	-1.28	-0.40	1.08	0.64	0.11	0.95
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	16	16	16	19	19	22	23	32	40	44
Reserves	-8.15	-8.64	-7.14	-6.77	-8.78	-14	-16	-9.59	17	48
Borrowings	27	20	19	15	16	15	1.75	1.61	0.45	0.00
Other Liabilities	12	17	29	35	36	55	51	69	107	126
Total Liabilities	47	44	58	62	62	77	60	93	164	217
Fixed Assets	32	29	29	27	28	30	32	31	31	53
CWIP	0.61	0.90	0.31	0.01	0.66	0.98	0.00	0.15	4.11	0.29
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	15	14	28	35	34	46	28	62	129	164
Total Assets	47	44	58	62	62	77	60	93	164	217

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	0.47	6.38	0.01	-1.71	3.46	3.72	1.07	-8.49	-26	-10
Cash from Investing Activity	0.09	0.35	0.29	1.83	-3.62	-3.77	-0.78	-1.65	-6.46	-22
Cash from Financing Activity	-0.54	-6.80	-0.15	-0.01	-0.02	-0.06	-0.28	11	32	34
Net Cash Flow	0.02	-0.07	0.14	0.11	-0.18	-0.11	0.00	0.54	-0.48	2.04

Oscillators

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Overview

Detailed Summary

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

Market Cap

210 Cr

Volatility

Moderate Risk

P/E Ratio

46.5

Industry P/E

30.8

PEG Ratio

—

P/B Ratio

2.2

52W High

62.00

52W Low

35.33

Sales CAGR

65.42%

80.54%

34.42%

10Y

67.52%

Profit CAGR

-83.33%

—

10Y

—

ROE

TTM

4.78%

4.54%

0.25%

10Y

-1.74%

ROCE

TTM

5.68%

5.54%

0.89%

10Y

-0.63%

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
LYKALABS	77.30	276 Cr	135.61	2.73	0.00	2.03	4.68	1.50
AMBASARABH	29.09	223 Cr	14.26	1.51	0.00	10.60	10.22	3.70
SYSCHEM	48.55	210 Cr	46.49	2.22	0.00	4.78	5.68	2.49
NATCAPSUQ	186.00	192 Cr	—	0.85	0.00	-4.87	-1.11	-2.84
ALPA	80.08	170 Cr	9.11	0.93	0.00	10.18	12.57	7.85
BALAXI	29.04	160 Cr	11.04	0.67	0.00	6.09	7.48	4.50
SOTAC	123.40	136 Cr	17.76	2.56	0.00	15.37	16.39	8.19